MACD Oscillator Analysis for AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) for the period of 9-Day stands at 1.26% while the stochastic %D for the same period stands at 2.03%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)’s 20-Day Bollinger Band indicates “Hold”.

About Company

AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of pain. The Company product candidates comprises: ARX-01 or the SufentanilNanoTab PCA System; ARX-02 or the SufentanilNanoTab BTP Management System; and ARX-03 or the Sufentanil/TriazolamNanoTab which are in their development stage. Its product ARX-01 is focused on acute post-operative pain, ARX-02 is focused on the treatment of cancer breakthrough pain and ARX-03 is focused on providing mild sedation, anxiety reduction, and pain relief to patients undergoing painful procedures in a physician’s office. AcelRx Pharmaceuticals, Inc. is headquartered in Redwood City, California.

Previous Day Activity Analysis

On the last trading day, AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) opened the session at $1.75 and closed at $1.75. The stock gained 0 points in the last trade.

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)’s stock fluctuated in the range of $1.70 and $1.75 during the previous active session. AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) traded with the volume of 1.64 Million with average volume of 2.24 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 3 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.47 and 27.79 respectively.

Currently the Insider Ownership of the shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is at 1.3% and the shares outstanding are 45.93 Million.

Important Ratio Analysis

Some important ratios to consider here for AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) are discussed below:

The Price to Sale P/S and Price to Book P/B shows the value of 5.15 and 0 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 0 and 0 correspondingly.

The Quick Ratio of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) stands at 4.8 while the Current Ratio depicts the value of 4.9.

Return on Assets ROA of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is at -53.3% whereas, Return on Equity ROE and Return of Investment ROI of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) stand at 372.6% and -35.7% respectively.

Stock Performance Analysis

The stock performance of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) on the basis of 5 day trade show the dip of -67.29% whereas, the monthly performance of the stock shows decrease of -45.31%.

The quarterly performance of the stock remained in red zone with the value of -43.55% while six month performance of the shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) remained bearish with the count of -35.19%.

The yearly and YTD performance of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) remained down at -46.97% and -32.69% respectively.